{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:56:36Z","timestamp":1782435396112,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajgponline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jagp.2019.03.021","type":"journal-article","created":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T02:30:36Z","timestamp":1554517836000},"page":"920-931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Sertraline and Mirtazapine Versus Placebo in Subgroups of Depression in Dementia: Findings From the HTA-SADD Randomized Controlled Trial"],"prefix":"10.1016","volume":"27","author":[{"given":"Marij","family":"Zuidersma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kia-Chong","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Oude","family":"Voshaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sube","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2019.03.021_bib0001","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/YCO.0b013e32834bb9d4","article-title":"Depression in dementia: epidemiology, mechanisms, and treatment","volume":"24","author":"Enache","year":"2011","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.jagp.2019.03.021_bib0002","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/gps.930060607","article-title":"Affective symptoms in Alzheimer's disease","volume":"6","author":"Burns","year":"1991","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2019.03.021_bib0003","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1176\/ajp.146.11.1472","article-title":"Dementia with coexistent major depression","volume":"146","author":"Greenwald","year":"1989","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2019.03.021_bib0004","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/(SICI)1099-1166(199606)11:6<507::AID-GPS337>3.0.CO;2-U","article-title":"Depression in dementia sufferers: a review","volume":"11","author":"Ballard","year":"1996","journal-title":"Int J Geriatr Psychiatry"},{"issue":"12 Suppl","key":"10.1016\/j.jagp.2019.03.021_bib0005","first-page":"5","article-title":"American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's Disease and other dementias. Second edition","volume":"164","author":"Rabins","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2019.03.021_bib0006","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/jgs.12210","article-title":"Pharmacotherapeutic management of dementia across settings of care","volume":"61","author":"Rattinger","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jagp.2019.03.021_bib0007","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1111\/j.1532-5415.2011.03660.x","article-title":"Psychotropic medication burden and factors associated with antipsychotic use: an analysis of a population-based sample of community-dwelling older persons with dementia","volume":"59","author":"Rhee","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jagp.2019.03.021_bib0008","first-page":"1","article-title":"Antidepressants for treating depression in dementia","volume":"8","author":"Dudas","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jagp.2019.03.021_bib0009","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archpsyc.60.7.737","article-title":"Treating depression in Alzheimer disease: Efficacy and safety of sertraline therapy, and the benefits of depression reduction: The DIADS","volume":"60","author":"Lyketsos","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jagp.2019.03.021_bib0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/JGP.0b013e3181c796eb","article-title":"Sertraline for the treatment of depression in Alzheimer disease","volume":"18","author":"Rosenberg","year":"2010","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2019.03.021_bib0011","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/JGP.0b013e3181cc0333","article-title":"Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes","volume":"18","author":"Weintraub","year":"2010","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2019.03.021_bib0012","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/gps.4566","article-title":"What is the therapeutic value of antidepressants in dementia? A narrative review","volume":"32","author":"Farina","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2019.03.021_bib0013","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40266-016-0434-6","article-title":"Management of depression in patients with dementia: is pharmacological treatment justified?","volume":"34","author":"Ford","year":"2017","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jagp.2019.03.021_bib0014","series-title":"Dementia: Assessment, Management and Support for People Living With Dementia and Their Carers","year":"2018"},{"key":"10.1016\/j.jagp.2019.03.021_bib0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(11)60830-1","article-title":"Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial","volume":"378","author":"Banerjee","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jagp.2019.03.021_bib0016","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0006-3223(88)90038-8","article-title":"Cornell Scale for Depression in Dementia","volume":"23","author":"Alexopoulos","year":"1989","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jagp.2019.03.021_bib0017","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1017\/S003329171600297X","article-title":"Longitudinal associations between late-life depression dimensions and cognitive functioning: a cross-domain latent growth curve analysis","volume":"47","author":"Brailean","year":"2017","journal-title":"Psychol Med"},{"key":"10.1016\/j.jagp.2019.03.021_bib0018","first-page":"98","article-title":"Clinical presentation of the \u201cdepression-executive dysfunction syndrome\u201d of late life","volume":"10","author":"Alexopoulos","year":"2002","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2019.03.021_bib0019","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1037\/0021-843X.105.1.97","article-title":"The influence of depressive symptomatology on episodic memory functioning among clinically nondepressed older adults","volume":"105","author":"Backman","year":"1996","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/j.jagp.2019.03.021_bib0020","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00002093-198802040-00004","article-title":"Symptoms of \u201cdepression\u201d in dementia of the Alzheimer type","volume":"2","author":"Burke","year":"1988","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jagp.2019.03.021_bib0021","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1176\/jnp.1.3.236","article-title":"Dementia and depression: an evolving enigma","volume":"1","author":"Cummings","year":"1989","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jagp.2019.03.021_bib0022","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2019.03.021_bib0023","series-title":"Latent Structure Analysis","author":"Lazarsfeld","year":"1968"},{"key":"10.1016\/j.jagp.2019.03.021_bib0024","series-title":"Latent Class Analysis","author":"McCutcheon","year":"1987"},{"key":"10.1016\/j.jagp.2019.03.021_bib0025","series-title":"Mplus User's Guide (Seventh Edition)","author":"Muth\u00e9n","year":"2012"},{"key":"10.1016\/j.jagp.2019.03.021_bib0026","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/gps.1583","article-title":"Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS","volume":"21","author":"Mayer","year":"2006","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2019.03.021_bib0027","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/gps.2565","article-title":"Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study +\/- 2 (DIADS-2)?","volume":"26","author":"Drye","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2019.03.021_bib0028","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/mp.2015.53","article-title":"Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression","volume":"21","author":"Hieronymus","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jagp.2019.03.021_bib0029","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jamapsychiatry.2017.0025","article-title":"Reevaluatingthe efficacy and predictability of antidepressant treatments: a symptom clustering approach","volume":"74","author":"Chekroud","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jagp.2019.03.021_bib0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1192\/bjp.bp.108.057554","article-title":"Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression","volume":"194","author":"Uher","year":"2009","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jagp.2019.03.021_bib0031","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.brat.2013.03.010","article-title":"Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy","volume":"51","author":"Fournier","year":"2013","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.jagp.2019.03.021_bib0032","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn3475","article-title":"Power failure: why small sample size undermines the reliability of neuroscience","volume":"14","author":"Button","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jagp.2019.03.021_bib0033","first-page":"1","article-title":"Practice guideline for the treatment of patients with major depressive disorder (third edition). American Psychiatric Association","volume":"167","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2019.03.021_bib0034","series-title":"Depression: the treatment and management of depression in adults (partial update of NICE clinical guideline 23)","year":"2009"},{"key":"10.1016\/j.jagp.2019.03.021_bib0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/acps.12886","article-title":"Initial severity of major depression and efficacy of new generation antidepressants: individual participant data meta-analysis","volume":"137","author":"Furukawa","year":"2018","journal-title":"Acta Psychiatr Scand"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S106474811930332X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S106474811930332X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:27:54Z","timestamp":1761020874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S106474811930332X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S106474811930332X"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2019.03.021","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sertraline and Mirtazapine Versus Placebo in Subgroups of Depression in Dementia: Findings From the HTA-SADD Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2019.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of American Association for Geriatric Psychiatry.","name":"copyright","label":"Copyright"}]}}